---
category: news
title: "European Medicines Agency Validates Application for Tepotinib for the Treatment of Advanced NSCLC with METex14 Skipping Alterations"
excerpt: "Merck, a leading science and technology company, today announced that the European Medicines Agency (EMA) has validated for review,"
publishedDateTime: 2020-11-27T02:07:00Z
originalUrl: "https://www.prnewswire.com/in/news-releases/european-medicines-agency-validates-application-for-tepotinib-for-the-treatment-of-advanced-nsclc-with-metex14-skipping-alterations-868437423.html"
webUrl: "https://www.prnewswire.com/in/news-releases/european-medicines-agency-validates-application-for-tepotinib-for-the-treatment-of-advanced-nsclc-with-metex14-skipping-alterations-868437423.html"
type: article
quality: 0
heat: 0
published: false

provider:
  name: PR Newswire
  domain: prnewswire.com

topics:
  - AI

images:
  - url: "https://mma.prnewswire.com/media/1136775/Merck_Logo.jpg?p=facebook"
    width: 1063
    height: 557
    isCached: true

secured: "nFDnT+JdvH9Yt7r9+afEL8TJUtoWrVyN0nvabFIXIc3QiGM9kLn5imtn9yI3klaaXOXFWQCdjqCCGI9iNmhCnrf9q41leYy7el8G6YJ99zzQe28UXbZeEud3YwStrjyTLC3CAw5eYSKuvEDJDuf+cwGxoBOOy2C5mmzBslTKRYw9HIHV/5qUJxtilgButQYOZAv+0HeTRhjjogAkqhibmSpflB2eCA0F2pqHYUVFhH0OQJqPGAF3TtlaC9im38PM+UEt2KLxFBg5BZi35tw4UMW/vMeum7pX9hhtZTBIl1hf1xxY81wtAO+fBhO2meyZ9Vex2S06UQONQNd2cDLoge7XrAcSR5RpavpyobRSLa4=;FJ3nxulVBtNDBxknqHnK9g=="
---

